Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipopolysaccharide (LPS) phosphate groups are essential anionic components located primarily on the Lipid A moiety and the core oligosaccharide of Gram-negative bacteria (Raetz et al., 2007, Annual Review of Biochemistry). These negatively charged groups are critical for maintaining the structural integrity of the bacterial outer membrane by cross-linking with divalent cations like magnesium and calcium (Trimble et al., 2016, Cold Spring Harbor Perspectives in Medicine). In the context of human health, they play a dual role: they are the primary triggers for the innate immune response via the TLR4/MD-2 complex, leading to inflammation or sepsis, and they serve as the initial binding site for cationic antimicrobial agents (Park et al., 2009, Nature). Drugs such as polymyxins exploit these phosphate groups through electrostatic interactions, displacing the stabilizing cations and causing membrane permeabilization and cell death (Poirel et al., 2017, Clinical Microbiology Reviews). Consequently, modifications to these phosphate groups, such as the addition of phosphoethanolamine or 4-amino-4-deoxy-L-arabinose, are a major mechanism of bacterial resistance to last-resort antibiotics (Matin et al., 2021, Antibiotics). This target is of significant interest in the development of next-generation antibiotics designed to overcome resistance in multi-drug resistant (MDR) pathogens. Furthermore, the neutralization of these phosphate groups is a strategy being explored to mitigate the toxic effects of circulating endotoxins during severe infections.
Electrostatic binding to the negatively charged phosphate groups of Lipid A, followed by displacement of divalent cations (Mg2+ and Ca2+), which destabilizes the outer membrane and leads to increased permeability, leakage of intracellular contents, and cell death (Poirel et al., 2017, Clinical Microbiology Reviews).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipopolysaccharide (LPS) phosphate groups (LPS phosphate groups).